Related Experiment Video
Updated: Jun 23, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Optimizing heart failure pathways to enhance patient care: the Program to Optimize Heart Failure Patient Pathways
Ashish Patwala1, Diane Barker1, Antoine Da Costa2
1University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK.
The Program to Optimize Heart Failure Patient Pathways (PRO-HF) helps European hospitals identify and address gaps in heart failure care. Initial findings show common issues in specialist care, data management, and multidisciplinary teams, with tailored interventions showing promise.
Area of Science:
- Cardiology
- Healthcare Management
- Public Health
Background:
- European healthcare providers face challenges implementing integrated, multidisciplinary heart failure (HF) care pathways.
- The European Society of Cardiology recommends specific guidelines for HF management that are not consistently adopted.
- The PRO-HF program was developed to assist clinicians in evaluating and improving their HF patient pathways.
Purpose of the Study:
- To assess the current state of HF pathways in 10 European hospitals.
- To identify strengths, gaps, and areas for improvement in HF patient care.
- To support the development of tailored interventions for pathway optimization.
Main Methods:
- Baseline assessments involved holistic appraisals of HF services using a comprehensive checklist.
- Data collection included digital surveys for HF care teams and one-to-one interviews.
- Assessments covered four key areas: outpatient clinics, remote management, device implantation/inpatient pathways, and network maximization.
Main Results:
- Key areas for improvement identified across hospitals include HF specialist care provision, data capture and analysis, institutional care protocols, hospital-wide strategies, and multidisciplinary teams (MDTs).
- Suboptimal specialist care for emergency inpatients was noted in all hospitals.
- Lack of clear protocols and understaffed MDTs contributed to variability in care and hindered the adoption of new technologies like remote patient monitoring.
Conclusions:
- The PRO-HF program effectively identifies significant gaps and shortcomings in European hospital HF pathways.
- Preliminary results from hospitals implementing suggested changes are encouraging.
- Longer-term follow-up is necessary to fully ascertain the impact of PRO-HF on HF pathway optimization and patient outcomes.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: Diuretics
Heart Failure Drugs: Inotropic Agents
Heart Failure Drugs: β-Blockers
Pathophysiology of Cardiac Performance

